(Jeffries) Alcatel-Lucent - Mixed Quarter but the Nokia Deal is On

Mixed Quarter but the Nokia Deal is On Track… Where’s the Cost Savings?

Key Takeaway
- The Q1 results included a modestly higher-than-expected top line with
operating profitability that met expectations. We came away from the earnings
call feeling less confident about their ability to hit the full €950M Fixed Costs
savings target. Barring any surprises, we expect the Nokia transaction to move
forward. Our rating remains Hold.
- Nokia Deal Still on Track... CEO Michel Combes got asked numerous questions on the
pending deal. Management teams of both companies have stated that the deal will not be
affected by one poor quarter of results from Nokia. The Nokia transaction remains on track
to close in 1H’16.
- Negative Q1 Fixed Cost Savings? We’re Having Flashbacks to Prior
Restructurings... In Q1, the organization did not capture any Fixed Cost savings that
accrued to the bottom line. The company stated that all savings were reinvested back into
the business (R&D + Sales & Marketing). While they reaffirmed the €950 million expected
for Shift Plan savings by year-end 2015, it seems the Fixed Cost savings are getting harder
and harder to generate. Net savings have declined each of the past 3 quarters. The situation
reminds us of the company’s six prior restructurings (pre-Shift Plan) where they missed their
targets as savings were plowed back into the business. In total, we believe the industry may
simply be too competitive for Alcatel-Lucent to deliver on their cost savings targets and run
the business at high-single digit operating margins over sustained time periods.
- The Cash Performance Was Much Worse than Advertised… Per the headline figure
from the company --Net Cash at Q1-end was €262M, down versus €326M at Q4-end. On
the Balance Sheet however, Current Liabilities increased roughly €500M Q/Q after running
at very consistent levels (€1.2 to €1.4 billion) over the past 3 years. That certainly helped
cash look much better. The additional Q/Q increase in Receivables factoring also helped cash
balances.
- Tweaking Estimates… For 2016, our revenue and EPS projections move from €14.299
billion and €0.20 to €14.384 billion and €0.16. We continue to rate the shares a Hold and
expect the business to trade in-line with Nokia given the all-stock terms of the deal.
- Valuation/Risks
Risks: 1) Balance Sheet / Cash Burn; 2) management execution against the Shift Plan; and 3)
lumpiness in spending trends among the major North American service providers. Our new
Price Target is €3.50, which equates to the current consideration Alcatel-Lucent shareholders
will receive on the deal.

(JPM) Equity Strat. - How worrying is the latest move up in bond yields?

How worrying is the latest move up in bond yields?
Reflation was never a reason to be bearish on equities

* There were good arguments for volatility to increase in the short term –
elevated P/Es, strong prior run, position squaring in crowded trades, bad
seasonals etc – but the spike in bond yields should not be added to this list,
in our view. In fact, we think that the move up in bond yields is one of a range
of factors signaling that the next stage for the market will be the reflation
trade, and that the risk-off phase will not last beyond a few weeks:
* 1) Yields moving higher will end up an eventual positive. We note that in ‘13
the bond selloff drove a correction initially, only to be followed by a strong 2H
equity rally, where SPX moved up by 15%, despite 10 year yields selling off
150bp.
* Banks are helped when yields increase. There is a strong positive relationship
between the relative performance of BKX index and the 10 year yields, as per
top chart. The relative performances of Cyclical vs Defensive sectors and of
Value vs Growth styles are also linked to the bond yield direction. We note that
since the peak of SXXP on 27th April, the Defensive group has in fact
underperformed Cyclicals by 20bp, in the down market. We stay UW Utilities in
particular and stay OW Banks, even during the correction phase.
* 2) DXY rolling over is reflationary, as it underpins commodity prices. The
correlation between oil price and the equity markets, or indeed the oil and
earnings, remains resolutely positive. Stay OW Energy.
* 3) Inflation expectations are rising, reaching their highest level since last
November. This is in stark contrast to Q4 of last year when the collapse in
inflation expectations was pressuring equities, and Banks in particular.
* 4) M1 keeps moving up in Eurozone. This suggests there are further gains in
Eurozone PMIs in store for 2H. The peripheral PMIs in particular are breaking
out.
* 5) Credit is turning higher. Loan growth is bottoming out in Eurozone. Cost of
credit is coming down.
* May remains seasonally a poor time for risk trades, but we believe that, beyond
some potential further short-term position unwinding, the backdrop for the 2nd
half is looking increasingly encouraging. The signs of reflationary dynamics
taking hold should lead to the next leg higher in equities, driven by Banks,
commodities and Cyclicals. Among our key sector calls we are OW Banks and
OW Energy vs underweight Utilities and Staples, and are OW Cyclicals vs
Defensives.

(JPM) Syngenta - Further thoughts on Syngenta as an acquisition target

Syngenta (SYNN VX, UW – SF395.80, PT SF240.00) (Ben Scarlett)
Further thoughts on Syngenta as an acquisition target
In this note, we follow up on our earlier comments (link) regarding Syngenta as a potential
take-over target, and address some of the common questions posed to us by investors
following Monsanto’s bid. As a general comment, we expect discussions to persist and
the question is whether or not Monsanto elects to put the offer to Syngenta’s
shareholders, or indeed raises the offer. In our view, a deal appears achievable, with antitrust
restrictions likely to represent the greatest challenge, based on the presumption
Syngenta’s Board at some point accepts a bid. Finding a suitor for Syngenta’s Seeds
business – for which at least a partial disposal is likely to be required to fulfill anti-trust
requirements – is unlikely to pose a problem. However, there may prove to be greater
difficulties in meeting requirements with regards to disposals/sales of herbicide assets,
where a Monsanto-Syngenta combination would otherwise have a substantial market
share in North America and Latam, and in the non-selective markets globally. Overall, we
estimate 15-20% of Syngenta’s sales could be subject to anti-trust considerations. We
estimate potential synergies will likely be in the $600-700m region, but note this figure

The key issues we address in this note include:
1) Potential anti-trust considerations
2) Possible alternative bidders for Syngenta
3) Potential suitors for part disposals
4) Possible defense mechanisms for Syngenta
5) Synergies and other considerations

(JPM) Syngenta - Further thoughts on Syngenta as an acquisition target

Syngenta (SYNN VX, UW – SF395.80, PT SF240.00) (Ben Scarlett)
Further thoughts on Syngenta as an acquisition target
In this note, we follow up on our earlier comments (link) regarding Syngenta as a potential
take-over target, and address some of the common questions posed to us by investors
following Monsanto’s bid. As a general comment, we expect discussions to persist and
the question is whether or not Monsanto elects to put the offer to Syngenta’s
shareholders, or indeed raises the offer. In our view, a deal appears achievable, with antitrust
restrictions likely to represent the greatest challenge, based on the presumption
Syngenta’s Board at some point accepts a bid. Finding a suitor for Syngenta’s Seeds
business – for which at least a partial disposal is likely to be required to fulfill anti-trust
requirements – is unlikely to pose a problem. However, there may prove to be greater
difficulties in meeting requirements with regards to disposals/sales of herbicide assets,
where a Monsanto-Syngenta combination would otherwise have a substantial market
share in North America and Latam, and in the non-selective markets globally. Overall, we
estimate 15-20% of Syngenta’s sales could be subject to anti-trust considerations. We
estimate potential synergies will likely be in the $600-700m region, but note this figure

>>> Mediobanca confirms plans to sell stakes in Telecom Italia and other compani

Mediobanca confirms plans to sell stakes in Telecom Italia and other companies (translated)

Mediobanca, the listed Italian investment bank, has confirmed plans to sell its 1.16% stake in Telecom Italia, Italian language daily Il Sole 24 Ore reported.

Mediobanca CEO Alberto Nagel said the sale of the stake in TI and a 4.1% stake in listed Italian tyre maker Pirelli is slated for 3Q15.

Nagel also said that Mediobanca would reduce its stake in listed Italian insurer Generali from 13% to 10%, most likely in 1Q16, the report added. He further noted the shares could be used to make a buy in asset management, the article added.

Nagel also confirmed that Mediobanca planned to sell its 6% stake in listed Italian media group RCS but the timing of the sale would depend on the value of RCS' shares.

The report also cited Nagel as welcoming the entry of Vivendi into TI as “great news,” as Vivendi would act as a stable shareholder.

Telecom Italia has a market cap of EUR 19.46bn.


The original article appeared in print; Page 21
Il Sole 24 Ore

--> List of Medionaca Holding (According to bbg)
Generali G IM : 12.46% ~3.83bil
Pirelli PC IM : 3.95% ~ 325mil
RCS Mediagroup RCS IM 9.93% ~69mil
Italmobiliare IM IM 8.14% ~60mil
Nice NICE IM 3.19% 13mil
Piquadro PQ IM 6.33% ~5.8mil

(UBS) Syngenta - Monsanto likely to raise offer – Upgrade to Buy

Rejected CHF 449/share offer likely to be sweetened (with Monsanto equity)
We upgrade to Buy. From an analysis of historically achieved merger savings in the crop protection and seeds industry (peak savings in year 3 post deal of between 5-9% of combined sales ex antitrust divestments) we estimate a maximum bid premium of $19.53bn, or CHF 202/sh. Our base case share price scenario of CHF 475 would imply
that 70% of savings end with Syngenta shareholders. Monsanto could pay a strategic price above CHF 535/sh, based on our analysis. Next to financial/valuation headroom, industry logic dictates Mon's agenda we think: low crop prices, addition of chemistry to the tech toolbox, lack of white knights, a 'reboot' of the integrated offer.

EPS accretion/dilution from a Monsanto perspective yields the same conclusion
Constructing pro forma accounts for Monsanto leads us to conclude that the deal in its currently proposed (but rejected) form (ie CHF 449/share, 45% in cash) would accrete 12% to Monsanto's earnings. Assuming a raised offer via issuance of more equity, but no earnings accretion (ie another way of looking at a 'strategic M&A premium), we
compute a best case scenario offer price (from Syngenta's perspective) of CHF 540, broadly in line with the upside scenario computed via the savings route.

Antitrust manageable, white knights unlikely (timing), pressure on the top 6
We had (incorrectly) assumed that industry consolidation would start once the situation at Dow Chemical clears up. Dow and Du Pont are busy with asset deconsolidation and face activist pressure. A BASF/Syn combo would face significant antitrust in chemicals, no savings potential in Seeds and financing hurdles (BASF has never issued equity in its corporate history), although a potential end of the BASF/Mon collaboration in output traits would likely leave BASF isolated. Bayer's balance sheet is stretched (Merck OTC) but it is a potential bidder for assets that competition authorities mandate for disposals (UBSe c$3bn sales: non-selective herbicides, US corn seed, global soy, and vegetable seeds). If successful, the Mon/Syn combo will lead to mounting consolidation pressure.

Valuation: UBSe base case assumes Monsanto pays away 70% of $2bn savings
Having used a standalone DCF and multiples before, we set PT using the undisturbed share price plus NPV deal savings. Our base case of CHF475 implies that 70% of estimated savings are paid away to Syn shareholders. In our upside case of CHF535 shareholders receive 100% of deal savings (ie Monsanto paying a 'strategic' multiple).

(BFW) Afren Decides Not to Make Interest Payment on 2019 Bonds


Afren Decides Not to Make Interest Payment on 2019 Bonds
2015-05-11 06:19:47.39 GMT


By Benjamin Dow
(Bloomberg) -- Upon expiration of 30-day grace period,
board decides not to make $12.8m interest payment to preserve
cash until full restructuring has been completed.
* Statement

For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>

To contact the reporter on this story:
Benjamin Dow in Moscow at +7-495-771-7735 or
bdow2@bloomberg.net
Benjamin Dow

>>> What to look at today - 11th of May 2015

Nikkei225 and Shanghai Composite are leading the charge in the far east to open up the new trading week. The former - Nikkei225 - is benefiting from weaker Yen amid overall risk-on mode after the Wall St rally on Friday, even though the non-farm payrolls data were largely in line. Shanghai Composite meanwhile has added to a 2%+ rebound on Friday with another 1.1% rise after the weekend move by the PBoC to cut key rates for the 2nd time this year. The easing - a 25bp cut in deposit and lending rates to 2.25% and 5.10% respectively - was widely telegraphed by analysts following last week's downbeat trade numbers, though PBoC also noted it will continued to "promote real interest rates back towards reasonable levels" in response to the economy facing downward pressure. Meanwhile, economists with ANZ and Nomura anticipate further key rates moves by the PBoC amid powerful headwinds to the economy. Also out of China over the weekend and just ahead of the central bank easing, April CPI inflation rose by a decimal to a 4-month high of 1.5% but still missed expectations. YTD CPI of 1.3% was also underwhelming, as it remains well below the official 2015 target of 3.0%. Food CPI was once again much higher at 2.7% vs 0.9% for non-food, although Stats Bureau researcher said the "supply of meat and fresh vegetables has been stable, so there are no expectations of a sharp jump in food prices in the near term." EUR/USD is consolidating some of its recent gains, falling about 80pips below $1.1140. Greece remained in the headlines ahead of Monday meeting with European creditors, as PM Tsipras called for "clear confirmation of the progress that has been made" in expressing optimism that a breakthru at today's talks can be achieved. Earlier, Dep Foreign Min Tsakalotos (debt negotiation team) also said "the deal is very close and will be reached in the coming period."

Nikkei +1.22% Hang Seng +0.63% Shnaghai +2.14%

Eur$ 1.1146 RUB $51.2855 EURCHF 1.0415 CHF 0.9339 GBP 1.5418 WTI $59.31 (-0.13%)

S&P -0.01% EuroStoxx +0.06% Dax +0.05% SMI +0.12%


Macro :
- China Cuts 1-Year Interest Rates by 0.25 Percentage Point
- China Adds Stimulus With Third Interest-Rate Cut in Six Months
- Greece Cuts 2015 Growth Forecast, Reuters Reports
- Iran Can Raise Oil Exports by 500,000 Bpd Once Sanctions Lifted
- China April Consumer Prices Rise 1.5% Y/Y; Est. 1.6% Gain
- Greek Deal With Creditors to Unlock 7 Projects: Kathimerini
- German Fin Min Schaeuble: concerned about potential for surprise default in Greece; Germany will do everything to keep Greece in the eurozone 
- Norway Christian Democrats to Seek More Oil Fund Exclusions
- Merkel Pressed to Give Up on Greece as Germans Urge Strong Euro

Keep an eye on :
- ABBN VX : ABB CEO Tells SRF He Plans No Big Restructurings, Wants to Build
- AH NA : Ahold, Delahize Decline to Comment on Merger Talks Report
- AIR FP : Airbus A400M Crash, First Ever, Leaves 4 Dead, 2 Injured
- AIR FP : Airbus Says Test Flights of A400M Aircraft to Proceed: Reuters
- AF FP : Air France-KLM: Says April Passenger Traffic Flat
- AREVA FP : Areva-EDF Solution to Be Found Before Summer, Echos Says
- ATL IM : Atlantia 1Q Ebitda Misses; Italy Traffic +0.9%
- BARC LN : U.K. Banks May Get GBP4b Windfall From Visa Deal, Sky Reports
- BMPS IM : Monte Paschi Sees Possible Merger With Cooperative Banks: Sole
- BMW GY : BMW CEO Faces Investor Opposition to Chairmanship Move: FAS
- BP/ LN : US appeals court finds the company can appeal damages awards from oil spill in the Gulf of Mexico (Deepwater Horizon) - financial press - Court finds existing rules of settlement that gave the claims fund administrator full discretion on paying claims violated BP's rights by not providing it with acceptable methods to for it to appeal decisions.
- CA FP : Carrefour Brazil shareholder Diniz negotiating BRL 1bn raise from Qatari fund to boost stake 
- DPW GY : Deutsche Post Faces Strikes After Wage Talks Collapse: Ver.di
- GIL GY : DMG Mori Seiki AG to Be Renamed DMG Mori AG, CEO Says at AGM
- ERF FP : Eurofins Says It Can Easily Achieve 2015 Targets
- EXO IM : Exor Said to Weigh PartnerRe Bid Raise at Tues. Meeting: Reuters
- EXO IM : Exor Agrees to Sell Cushman & Wakefield to DTZ For $2b
- EXO IM : Exor may weight M&A alternative to Partnerre by 2015 - Repubblica
- FIS1V FH : Fiskars Buys WWRD Group of Companies for $437m
- GEA GY : GEA Group 1Q Ebitda Rises, Profit Drops; Raises Forecast
- MB IM : Mediobanca confirms plans to sell stakes in Telecom Italia and other companies - Il Sole 24 ore
- MEO GY : Metro plans to enter new markets; acquisitions possible -http://bit.ly/1K0OXz5
- ONTEX BB : Ontex 1Q Adj. Ebitda Rises 5.7% to EU52m; Targets Wider Margin
- PFV GY : Pfeiffer Vacuum may make large acquisitions- http://bit.ly/1ElK8JV
- QSC GY : QSC 1Q Rev. Falls 4%; Says Had Good Start to Yr, Keeps Forecast
- ROG VX : Roche to Present Pivotal Data in Lung, Blood Cancers at ASCO
- ROG VX : Roche Wins FDA Approval for Cobas KRAS Mutation Test
- SGO FP : Saint-Gobain Remains Open for Talks With Sika Board, CEO Says
- SCYR SM : Blackstone, Merlin Among Bidders for Sacyr’s Testa: Expansion
- SIE GY : EU Regulators Said Set to Unconditionally Clear SI/DRC: Reuters http://reut.rs/1Qwp9Ma
- SYNN VX : Syngenta trading higher in NYC on report of Shareholders backing a $50b deal
- SYNN VX : Monsanto to Pursue Syngenta Takeover After Bid Rejected: Reuters
- SYNN VX : Monsanto l ikely to sweeten Syngneta offer after rejection - UBS
- TLX GY : Talanx 1Q Net Rises 16% to EU251m; Sticks to Outlook
- TEVA IT : Mylan chairman tells investors he would consider buying Teva http://reut.rs/1H5lW1F
- UBER IPO : Uber Fund-Raising Points to $50 Billion Valuation - NYT
- V US : Said to be in early stage talks to buy Visa Europe for as much as $20B
- VASTN NA : Vastned Confirms 2015 Guidance for Direct Result/Share
- VOW3 GY : Skoda Auto Doesn’t See Quick Recovery of Russian Market: Wojnar
- WDF IM : World Duty Free sale faces demand for regulatory investigation after Benettons choose Dufry over higher Chinese bid - FT http://on.ft.com/1HbQeTa